Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Programs without a documented diagnosis, including lifestyle or coaching services, will not qualify
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes and obesity, have evolved into multi-organ potential therapeutics due to their pleiotropic effects beyond glycemic control
South Africas direct-to-consumer weight-loss medication market is supported by the rising adoption of mobile pharmacy units in rural and semi-urban regions
However, they have side effects including nausea, vomiting, diarrhea, dizziness, infection, headaches, and dyspepsia
US$ 24.30
US$ 26.47
US$ 22.58
US$ 24.98
US$ 29.11
US$ 21.61
US$ 25.95
